Share Email Print

Proceedings Paper

Review of dermatology use of 5-aminolevulinic acid photodynamic therapy in China from 1997 to 2013
Author(s): Peiru Wang; Guolong Zhang; Xiuli Wang
Format Member Price Non-Member Price
PDF $14.40 $18.00
cover GOOD NEWS! Your organization subscribes to the SPIE Digital Library. You may be able to download this paper for free. Check Access

Paper Abstract

The prodrug 5-aminolevulinic acid (ALA) and its ester derivatives have been used in photodynamic therapy (PDT) in dermatology worldwide. In China, ALA-PDT was first used to treat urethral condylomata acuminata and non-melanoma skin cancers in 1997. A powder formulation of ALA hydrochloride was approved by the Chinese Food and Drug Administration for the treatment of condylomata acuminata in 2007. Large successful experience of treating condylomatas was accumulated compared with Western countries. Meanwhile, numerous clinical studies as well as off-label use of ALAPDT have been carried out in China. To reflect the progress of ALA-PDT in China, several major Chinese and English databases were searched and published data were reviewed in this article.

Paper Details

Date Published: 15 July 2015
PDF: 15 pages
Proc. SPIE 9542, Medical Laser Applications and Laser-Tissue Interactions VII, 954206 (15 July 2015); doi: 10.1117/12.2183290
Show Author Affiliations
Peiru Wang, Shanghai Skin Disease Hospital (China)
Guolong Zhang, Shanghai Skin Disease Hospital (China)
Xiuli Wang, Shanghai Skin Disease Hospital (China)

Published in SPIE Proceedings Vol. 9542:
Medical Laser Applications and Laser-Tissue Interactions VII
Lothar D. Lilge; Ronald Sroka, Editor(s)

© SPIE. Terms of Use
Back to Top